Transkaryotic Factor VIII gene therapy: Beth Israel Deaconess Medical Center (Boston, Mass.) resumed TKTX's 12-patient Phase I safety study, which had been susp

Transkaryotic Therapies Inc. (TKTX), Cambridge, Mass.
Product: Transkaryotic Factor VIII

Read the full 104 word article

How to gain access

Continue reading with a
two-week free trial.